InvestorNewsBreaks - Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia(TM) Weight Loss Product

Stock Information for BioAdaptives, In

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About BioAdaptives, In

BioAdaptives® Announces Commercial Launch of MyndMed(TM) Following Successful Pilot Testing
BioAdaptives' MyndMed(TM) Receives Full Clearance from TruShield(TM), Meeting UFC and WADA Standards for Athlete Safety
BioAdaptives Announces National Launch of NeuroRush(TM) - A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
BioAdaptives Announces National Launch of Pawpa(TM) Regen
BioAdaptives® PawPa(TM) Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial
BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.